Roche Patent Case Against Nova Biomedical, Lifescan Revived
Roche Holding AG (ROG)’s diagnostics unit won an appeals court ruling that revives a patent-infringement case against Johnson & Johnson (JNJ)’s LifeScan unit and Nova Biomedical Corp. over glucose monitors.
The U.S. Court of Appeals for the Federal Circuit today said a judge should have considered the definition of a key term in the Roche patents for methods to determine the concentration of glucose in a blood sample. The court vacated a finding of non-infringement, and remanded the case for further proceedings.
To contact the reporter on this story: Susan Decker in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Michael Shepard at email@example.com
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.